Preferences of Patients with Type 1 Diabetes for Glucose Monitoring Devices: Results from a Discrete Choice Experiment in the UK and Canada
The Patient - Patient-Centered Outcomes Research · 10.11.2026
DOI: 10.1007/s40271-026-00851-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Patient - Patient-Centered Outcomes Research, online erschienen am 10.11.2026. Verfasst von Emma Tassie und 3 weiteren Autor:innen. Beteiligte Einrichtung: King's Health Economics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK. emma…. Die Arbeit nennt 30 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Regular self-monitoring of glucose levels is integral to diabetes management to achieve glycaemic control and reduce the risk of acute and long-term complications. Wearable glucose monitoring devices provide more comprehensive information on glucose fluctuations than traditional finger-prick testing. However, access restrictions contribute to inequalities in adoption. This study elicited the preferences of patients with type 1 diabetes in the UK and Canada for attributes of glucose monitoring devices. METHODS: An online discrete choice experiment was conducted among adults (aged ≥ 18 years) with type 1 diabetes. Respondents chose between standard finger-prick testing (usual care) and two hypothetical glucose monitoring devices described using six attributes: convenience of monitoring, time lag, level of information, alarm to signal low and high glucose levels, glycated haemoglobin level and time in range, and an out-of-pocket monthly cost. Responses were analysed using a mixed logit model, and marginal willingness to pay was calculated. A pooled model using country interaction terms was used to formally compare preferences across countries. RESULTS: The discrete choice experiment was completed by 112 UK and 102 Canadian respondents. Across countries, respondents preferred devices offering convenience, alarm capabilities, real-time glucose readings and more comprehensive glucose information. Preferences were broadly consistent across countries, with only preferences for alarm functionality differing significantly. However, substantial preference heterogeneity was observed within both countries, indicating variation in the device characteristics valued by individuals. CONCLUSIONS: Overall, the discrete choice experiment results indicate that adults with type 1 diabetes preferred characteristics relating to the newer glucose monitoring devices. Substantial variation in individual preferences suggests that access to a range of glucose monitoring devices may be important to accommodate differences in the characteristics patients value.
Autor:innen und Institutionen
- King's Health Economics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK. emma.tassie@kcl.ac.uk.
- Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.
- School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
- Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
- RTI Health Solutions, Manchester, England, UK.
Zitieren
APA
Tassie, E., Scotland, G., Bryan, S., & Watson, V. (2026). Preferences of Patients with Type 1 Diabetes for Glucose Monitoring Devices: Results from a Discrete Choice Experiment in the UK and Canada. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-026-00851-0
Vancouver
Tassie E, Scotland G, Bryan S, Watson V. Preferences of Patients with Type 1 Diabetes for Glucose Monitoring Devices: Results from a Discrete Choice Experiment in the UK and Canada. The Patient - Patient-Centered Outcomes Research. 2026. doi:10.1007/s40271-026-00851-0
BibTeX
@article{Tassie2026,
author = {Tassie, Emma and Scotland, Graham and Bryan, Stirling and Watson, Verity},
title = {Preferences of Patients with Type 1 Diabetes for Glucose Monitoring Devices: Results from a Discrete Choice Experiment in the UK and Canada},
journal = {The Patient - Patient-Centered Outcomes Research},
year = {2026},
doi = {10.1007/s40271-026-00851-0}
}
EUVIMED